Clinical Trial Update: Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

View source ↗

Summary

A completed clinical trial evaluated the immunogenicity and safety of an inactivated H1N1 swine-origin influenza monovalent vaccine in immunocompromised childre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza H1n1

Drugs mentioned

• Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine (Influenza vaccine, H1N1, inactivated, swine-origin, monovalent)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: H1N1 Pandemic Flu | Status: COMPLETED